(Q22241831)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11198061%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

meta-analysis

0 references

title

Refractory schizophrenia and atypical antipsychotics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11198061%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

0 references

1

D M Taylor

D M

Taylor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11198061%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

D Duncan-McConnell

2

D

Duncan-McConnell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11198061%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11198061%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychopharmacology

4 November 2019

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11198061%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11198061%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

409-418

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11198061%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11198061%20AND%20SRC:MED&resulttype=core&format=json

Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

The efficacy of the D2 and 5-HT2 antagonist risperidone (R 64,766) in the treatment of chronic psychosis. An open dose-finding study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

Olanzapine for patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

An open comparison of clozapine and risperidone in treatment-resistant schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

A case of treatment-refractory psychosis responsive to sertindole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

A retrospective study on the long-term efficacy of clozapine in 96 schizophrenic and schizoaffective patients during a 13-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

Treatment-resistant schizophrenia--the role of clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

The evolution of treatment resistance: biologic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine: results from a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

Clozapine therapy for older veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

An open trial of olanzapine in patients with treatment-refractory psychoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

High-dose olanzapine for treatment-refractory schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

Quetiapine for refractory schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

A pilot, open study on the treatment of refractory schizophrenia with risperidone and clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Clozapine in the treatment of 121 out-patients

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Clozapine response in treatment-refractory first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Clozapine in refractory schizophrenia. Preliminary findings

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Clozapine-olanzapine: a potentially dangerous switch. A report of two cases

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Effectivity of zotepine in refractory psychoses: possible relationship between zotepine and non-dopamine psychosis

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Schizophrenia and schizoaffective disorder treated with high doses of olanzapine

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Olanzapine for treatment-refractory psychosis in patients responsive to, but intolerant of, clozapine

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Risperidone for treatment-refractory schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Is risperidone a substitute for clozapine for patients who do not respond to neuroleptics?

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Switching between clozapine and risperidone treatment

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

The safety and efficacy of clozapine in severe treatment-resistant schizophrenic patients in the UK. Clozapine Study Group

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Risperidone response after no clozapine response

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Use of clozapine in a child with treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Clozapine response in early treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Efficacy of risperidone in reducing positive and negative symptoms in medication-refractory schizophrenia: an open prospective study

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Clinical and neurocognitive effects of clozapine and risperidone in treatment-refractory schizophrenic patients: a prospective study.

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

Switching from clozapine to olanzapine in treatment-refractory schizophrenia: safety, clinical efficacy, and predictors of response.

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400411

7 January 2021

10.1177/026988110001400411

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11198061%20AND%20SRC:MED&resulttype=core&format=json

release_szbxvns7zbcfhm5452xnoilacm

4 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/szbxvns7zbcfhm5452xnoilacm

24 November 2022

mapped directly with Wikidata item

1 reference